DA32 LIFE SCIENCE TECH ACQUISITION CORP.

(DALS)
Delayed Nasdaq  -  05/10 03:19:48 pm EDT
9.710 USD   +0.10%
05/13DA32 LIFE SCIENCE TECH ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
05/13DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
03/31DA32 LIFE SCIENCE TECH ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)
AQ
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

DA32 Life Science Tech Acquisition Corp.(NasdaqCM:DALS) added to NASDAQ Composite Index

07/29/2021 | 12:00am EDT

DA32 Life Science Tech Acquisition Corp. has been added to NASDAQ Composite Index


ę S&P Capital IQ 2021
All news about DA32 LIFE SCIENCE TECH ACQUISITION CORP.
05/13DA32 LIFE SCIENCE TECH ACQUISITION CORP. Management's Discussion and Analysis of Finan..
AQ
05/13DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the First Quarter..
CI
03/31DA32 LIFE SCIENCE TECH ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINAN..
AQ
03/31DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the Eight Months ..
CI
01/23Certain Class B Common Stock of DA32 Life Science Tech Acquisition Corp. are subject to..
CI
2021DA32 LIFE SCIENCE TECH ACQUISITION CORP. Management's Discussion and Analysis of Finan..
AQ
2021DA32 LIFE SCIENCE TECH ACQUISITION C : Other Events (form 8-K)
AQ
2021DA32 LIFE SCIENCE TECH ACQUISITION C : Sponsored by Deerfield, ARCH Venture Partners and S..
BU
2021DA32 LIFE SCIENCE TECH ACQUISITION C : Entry into a Material Definitive Agreement, Unregis..
AQ
2021DA32 Life Science Tech Acquisition Corp. Announces Executive Changes
CI
More news
Financials (USD)
Sales
Net income
Net Debt
P/E ratio
Yield
Capitalization 249 M 249 M -
EV / Sales -1
EV / Sales 0
Nbr of Employees -
Free-Float 74,9%
Chart DA32 LIFE SCIENCE TECH ACQUISITION CORP.
Duration : Period :
DA32 Life Science Tech Acquisition Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DA32 LIFE SCIENCE TECH ACQUISITION CORP.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Managers and Directors
Steven J. Kafka Chief Executive Officer & Director
Christopher E. Wolfe Chief Financial Officer & Secretary
Mara G. Aspinall Independent Director
E. Kevin Hrusovsky Independent Director
Nicolas Henry Roelofs Independent Director
Sector and Competitors